Metraipolis › archive › dc_d27259ed2ffe
Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study) — Europe PMC PMID:41585216
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41585216
- DOI
- 10.3389/fmed.2025.1704081
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T22:37:25.707Z
- SHA-256 of the archived text
3a0d7af32b4fc45fa97387c0a1f5eb5041dab50fce66cead627af02acf13c809- Stable URL of this page
https://metraipolis.com/documento/dc_d27259ed2ffe
How to cite
Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study) — Europe PMC PMID:41585216 — Europe PMC (en), https://europepmc.org/article/MED/41585216 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d27259ed2ffe (Metraipolis archive dc_d27259ed2ffe, sha256 3a0d7af32b4fc45fa97387c0a1f5eb5041dab50fce66cead627af02acf13c809)
BibTeX
@misc{dcd27259ed2ffe,
title = {Real-world use of ixekizumab for axial spondyloarthritis treatment in Spain (ESPADA study) — Europe PMC PMID:41585216},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41585216},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d27259ed2ffe; sha256 3a0d7af32b4fc45fa97387c0a1f5eb5041dab50fce66cead627af02acf13c809},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41585216. Agents can read the archived copy with the MCP tool read_document.